Old Web
English
Sign In
Acemap
>
authorDetail
>
Jay A. Barth
Jay A. Barth
Amicus Therapeutics
in patient
Fabry disease
Medicine
outcome measures
open label
2
Papers
10
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrument.
2021
Quality of Life Research
Alan L. Shields
Re Lamoureux
Fiona Taylor
Jay A. Barth
Andrew E. Mulberg
Vivian Kessler
Nina Skuban
Show All
Source
Cite
Save
Citations (1)
Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study
2020
Molecular Genetics and Metabolism
Ulla Feldt-Rasmussen
Derralynn Hughes
Gere Sunder-Plassmann
Suma P. Shankar
Khan Nedd
Iacopo Olivotto
Damara Ortiz
Toya Ohashi
Takashi Hamazaki
Nina Skuban
Julie Yu
Jay A. Barth
Kathleen Nicholls
Show All
Source
Cite
Save
Citations (9)
1